$DUKR

2024 Q4 Form 10-Q Financial Statement

#000121390024097438 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $72.00K $0.00
YoY Change
Cost Of Revenue $41.00K
YoY Change
Gross Profit $31.00K
YoY Change
Gross Profit Margin 43.06%
Selling, General & Admin $173.0K
YoY Change -22.42%
% of Gross Profit
Research & Development $20.00K $0.00
YoY Change -100.0%
% of Gross Profit 64.52%
Depreciation & Amortization $6.000K
YoY Change 500.0%
% of Gross Profit
Operating Expenses $20.00K $173.0K
YoY Change -88.44% 1472.73%
Operating Profit -$218.0K -$173.0K
YoY Change 26.01% -26.07%
Interest Expense $23.00K
YoY Change -675.0%
% of Operating Profit
Other Income/Expense, Net $7.000K $23.00K
YoY Change -69.57%
Pretax Income -$150.0K
YoY Change -36.97%
Income Tax
% Of Pretax Income
Net Earnings -$211.0K -$150.0K
YoY Change 40.67% -36.97%
Net Earnings / Revenue -293.06%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 54.22M shares 54.22M shares 54.22M shares
Diluted Shares Outstanding 54.67M shares 54.56M shares

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.358M
YoY Change -21.66%
Cash & Equivalents $1.436M $2.358M
Short-Term Investments
Other Short-Term Assets $40.00K $285.0K
YoY Change -85.96% 691.67%
Inventory
Prepaid Expenses
Receivables $72.00K
Other Receivables
Total Short-Term Assets $1.578M $2.643M
YoY Change -40.3% -13.23%
LONG-TERM ASSETS
Property, Plant & Equipment $99.00K $52.00K
YoY Change 90.38% 136.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $128.0K
YoY Change 753.33%
Total Long-Term Assets $177.0K $180.0K
YoY Change -1.67% 386.49%
TOTAL ASSETS
Total Short-Term Assets $1.578M $2.643M
Total Long-Term Assets $177.0K $180.0K
Total Assets $1.755M $2.823M
YoY Change -37.83% -8.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $115.0K $82.00K
YoY Change 40.24% -5.75%
Accrued Expenses $50.00K
YoY Change -50.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $289.0K $452.0K
YoY Change -36.06% 140.43%
LONG-TERM LIABILITIES
Long-Term Debt $311.0K
YoY Change 2.64%
Other Long-Term Liabilities $54.00K
YoY Change
Total Long-Term Liabilities $365.0K
YoY Change 20.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $289.0K $452.0K
Total Long-Term Liabilities $365.0K
Total Liabilities $617.0K $817.0K
YoY Change -24.48% 66.4%
SHAREHOLDERS EQUITY
Retained Earnings -$10.88M -$9.528M
YoY Change 14.14% 37.83%
Common Stock $12.01M $5.000K
YoY Change 240160.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.138M $2.006M
YoY Change
Total Liabilities & Shareholders Equity $1.755M $2.823M
YoY Change -37.83% -8.43%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$211.0K -$150.0K
YoY Change 40.67% -36.97%
Depreciation, Depletion And Amortization $6.000K
YoY Change 500.0%
Cash From Operating Activities -$260.0K
YoY Change 80.56%
INVESTING ACTIVITIES
Capital Expenditures $2.000K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$2.000K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities -260.0K
Cash From Investing Activities -2.000K
Cash From Financing Activities
Net Change In Cash -262.0K
YoY Change 81.94%
FREE CASH FLOW
Cash From Operating Activities -$260.0K
Capital Expenditures $2.000K
Free Cash Flow -$262.0K
YoY Change 81.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Gross Profit
GrossProfit
usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
us-gaap Revenues
Revenues
usd
CY2023Q3 us-gaap Revenues
Revenues
usd
us-gaap Cost Of Revenue
CostOfRevenue
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55504
dei Entity Registrant Name
EntityRegistrantName
DUKE Robotics Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3052410
dei Entity Address Address Line1
EntityAddressAddressLine1
10 HaRimon Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Mevo Carmel Science and Industrial Park
dei Entity Address Country
EntityAddressCountry
IL
dei Entity Address City Or Town
EntityAddressCityOrTown
Israel
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
2069203
dei City Area Code
CityAreaCode
+972
dei Local Phone Number
LocalPhoneNumber
4-8124101
dei Security12b Title
Security12bTitle
N/A
dei No Trading Symbol Flag
NoTradingSymbolFlag
true
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54218813 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1436000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2281000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
30000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
40000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
41000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1578000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
2322000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
117000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
99000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
40000 usd
CY2024Q3 us-gaap Assets
Assets
1755000 usd
CY2023Q4 us-gaap Assets
Assets
2479000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
115000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
98000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
122000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
161000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
289000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
311000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
617000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
671000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54218813 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54218813 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54218813 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54218813 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
12008000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
11750000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10875000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9947000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1138000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1808000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1755000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2479000 usd
us-gaap Revenues
Revenues
72000 usd
CY2024Q3 us-gaap Revenues
Revenues
72000 usd
us-gaap Cost Of Revenue
CostOfRevenue
41000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
41000 usd
us-gaap Gross Profit
GrossProfit
31000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
31000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
137000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
636000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
581000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
229000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
173000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-742000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-581000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-218000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-173000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
44000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
69000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23000 usd
us-gaap Net Income Loss
NetIncomeLoss
-698000 usd
us-gaap Net Income Loss
NetIncomeLoss
-512000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-211000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-150000 usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54645820 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54645820 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54533236 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54533236 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54668813 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54668813 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
54556313 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
54556313 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1808000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
15000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-209000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1614000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
12000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-278000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1348000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-211000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1138000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2426000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
39000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-179000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2286000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
34000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-183000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2137000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
19000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-150000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2006000 usd
us-gaap Net Income Loss
NetIncomeLoss
-698000 usd
us-gaap Net Income Loss
NetIncomeLoss
-512000 usd
us-gaap Depreciation
Depreciation
17000 usd
us-gaap Depreciation
Depreciation
8000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
28000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
92000 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
6000 usd
us-gaap Financing Interest Expense
FinancingInterestExpense
6000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
39000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
32000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-38000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-42000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
72000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
193000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
17000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-39000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
143000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-739000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-469000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
76000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-76000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-815000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-491000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2281000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2849000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1466000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2358000 usd
usdr Initial Recognition Of Operating Lease Rightofuse Assets
InitialRecognitionOfOperatingLeaseRightofuseAssets
146000 usd
usdr Initial Recognition Of Operating Lease Liability
InitialRecognitionOfOperatingLeaseLiability
146000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">The preparation of unaudited condensed consolidated interim financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, certain revenues and expenses, and disclosure of contingent assets and liabilities as of the date of the financial statements. Actual results could differ from those estimates.</p>
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P3Y
CY2022Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P2Y
CY2022Q2 usdr Lease Payment Percentage Increase
LeasePaymentPercentageIncrease
0.05 pure
CY2022Q2 us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
15000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
41000 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
27000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
44000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
36000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
146000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
78000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
117000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
46000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
60000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
98000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M2D
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M2D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0875 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0875 pure
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
13000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
51000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
64000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
60000 usd
CY2024Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
230000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
28000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice
0.06
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
28000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
92000 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19000 usd
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
usd
us-gaap Gross Profit
GrossProfit
usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
usdr Initial Recognition Of Operating Lease Rightofuse Assets
InitialRecognitionOfOperatingLeaseRightofuseAssets
usd
usdr Initial Recognition Of Operating Lease Liability
InitialRecognitionOfOperatingLeaseLiability
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001638911

Files In Submission

Name View Source Status
0001213900-24-097438-index-headers.html Edgar Link pending
0001213900-24-097438-index.html Edgar Link pending
0001213900-24-097438.txt Edgar Link pending
0001213900-24-097438-xbrl.zip Edgar Link pending
ea0219984-10q_duke.htm Edgar Link pending
ea021998401ex3-2_duke.htm Edgar Link pending
ea021998401ex3-3_duke.htm Edgar Link pending
ea021998401ex31-1_duke.htm Edgar Link pending
ea021998401ex31-2_duke.htm Edgar Link pending
ea021998401ex32-1_duke.htm Edgar Link pending
ea021998401ex32-2_duke.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usdr-20240930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
usdr-20240930_def.xml Edgar Link unprocessable
usdr-20240930_lab.xml Edgar Link unprocessable
ea0219984-10q_duke_htm.xml Edgar Link completed
usdr-20240930_pre.xml Edgar Link unprocessable
usdr-20240930_cal.xml Edgar Link unprocessable